Berlin, Germany 6/20/16—Bruker has announced the acquisition of Yingsheng Technology for an undisclosed amount. Yingsheng’s Advanced Mineral Identification and Characterization System (AMICS) software package is designed for advanced minerals identification and characterization. AMICS is used with SEMs, energy dispersive x-ray spectrometers (EDS) and micro-XRF analyzers. “Making AMICS an integral part of our QUANTAX EDS systems […]

Birkenfeld, Germany 6/8/16—STRATEC Biomedical, a provider of automated analyzers, has purchased Sony DADC BioSciences from Sony for approximately €30 million ($34 million = €0.88 = $1). Headquartered in Anif, Austria, with 120 employees, Sony DADC BioSciences provides OEM consumables for diagnostics, life sciences and medical technology applications. For the year ending March 31, Sony DADC […]

As pharmaceutical companies expand their presence in emerging regions’ middle-class markets, they are incorporating new categories of products, including large-molecule biologics (i.e., monoclonal antibodies), and new gene and cell therapies. The biologics market is forecast to jump to $278 billion by 2020, a 71.6% increase from 2014. According to a survey of 254 pharmaceutical executives, […]

State health labs in the US have received government funding to purchase sequencers from companies such as Illumina and Thermo Fisher Scientific’s Life Technologies. Congress aims to equip public health labs in all states with the ability to conduct whole genome sequencing for the detection and study of drug-resistant bacteria by 2018. Each year, antibiotic-resistant […]

The growing use of technologies in agriculture is helping turn farms into factories. Known as “precision farming” or “precision agriculture,” this evolving method of agriculture aims to increase productivity in farms while keeping costs low. Genome editing is a key aspect of precision farming, as it is used to develop an understanding of the genomic […]

In a survey of 400 respondents examining corporate R&D spending in 10 Central European countries (Croatia, Czech Republic, Estonia, Hungary, Lithuania, Latvia, Poland, Romania, Slovakia, Slovenia), 45% of companies plan to increase R&D spending in the next 1–2 years, and 57% plan to increase it in the next 3–5 years. Respondents in Slovakia, Croatia and […]

Globally, IPOs in the biotechnology industry have slowed in the first quarter; however, biotech venture capital (VC) in the UK has remained strong since 2015, accounting for 27%, or £178 million ($201.8 million), of the EU’s total biotech VC financing. In 2015, £489 million was raised in VC, a 51.4% increase. The 2015 trend of […]